What to do when you reach your goal weight on Mounjaro

The biggest misconception: goal weight doesn't mean job done

Many people assume that reaching their target weight marks the natural end of treatment, the way finishing a course of medication for an infection would. That's not how tirzepatide works, and it's not what the evidence suggests. Mounjaro works in part by altering appetite signalling and slowing how quickly food leaves your stomach. When treatment stops, those effects stop too. The biology that made weight management difficult in the first place doesn't disappear because a number on the scales did.

What the trial data actually shows is that people who stopped tirzepatide after a period of significant weight loss tended to regain a meaningful proportion of that weight within a year, not because they lacked effort, but because the physiological support was removed. This is covered clearly in the NHS tirzepatide medicines page, which explains that treatment is intended alongside lifestyle changes, not instead of them. The lifestyle piece becomes load-bearing once the medicine is no longer doing part of the work.

None of this means you'll be on Mounjaro forever. It means the question of what happens at goal weight is a clinical one, not a simple admin tick. If you're wondering when you start losing weight on Mounjaro and what that trajectory looks like across the full course of treatment, the Mounjaro and weight loss page covers the evidence in more detail. The short version: reaching your goal is the start of a new phase, not the finish line.

What your options actually look like once you've hit your target

There are broadly three routes, and your prescriber will help work out which fits your situation. The first is staying at your current dose if your weight is stable and your health markers support continuing. Some people remain on tirzepatide long-term at the lowest effective dose, using it as ongoing maintenance rather than as a temporary tool. This reflects how chronic weight management conditions are increasingly understood in medicine, not as something you fix once, but something you manage.

The second option is a gradual step-down, reducing from your maintenance dose to lower strengths over a period of weeks, watching how your appetite, weight and general wellbeing respond at each level. This isn't something you'd do by feel alone; it involves the same kind of clinical re-review that every dose increase did. One useful checking habit: weigh yourself at the same time each morning for a week after any dose change, note the trend rather than single daily numbers, and bring that pattern to your next review. A single day's reading tells you almost nothing; a week's trend tells you a great deal.

The third route is stopping outright, usually considered when lifestyle habits are well-established, weight has been stable for a sustained period, and the prescriber is confident the foundations are solid enough to hold independently. If you're thinking about what stopping looks like in practice, when weight loss plateaus on Mounjaro gives useful context on how the medicine's effects shift over time.

Weight regain after stopping: what the evidence says and what it doesn't

It's worth being straightforward here. Studies on people who stopped semaglutide (Mounjaro's closest comparator class) showed average regain of around two-thirds of lost weight within a year of stopping. Tirzepatide data points in a similar direction. The NICE technology appraisal for tirzepatide (TA1026) notes that the benefits of treatment need to be weighed against the likelihood of weight regain after stopping, which is part of why the recommendation doesn't include a fixed duration limit in the way that the Wegovy appraisal does.

This doesn't mean regain is certain or that stopping is the wrong call, for some people, the lifestyle changes made during treatment genuinely do hold. But it's honest to say that for many, the medicine is doing meaningful physiological work that doesn't transfer automatically to willpower. Understanding this before you reach your goal helps you plan. The page on whether weight comes back after stopping Mounjaro covers this in full, including what the research actually shows versus what's often assumed.

For context on how pricing factors into long-term treatment decisions, the Mounjaro UK price changes page is worth reading if cost is part of your planning.

Having the goal-weight conversation with your prescriber

The most practical thing you can do when you're approaching your target (not once you've passed it) is raise this directly in your next clinical review. Ask what your prescriber thinks an appropriate maintenance phase looks like, whether a step-down or continuation makes more sense for your specific situation, and what markers they'd use to judge success. That conversation is easier to have with a clear head than in the moment of hitting a number you've been working toward for months.

At nume, every repeat order goes through a fresh clinical assessment, a real prescriber, not an automated process, looks at where you are before anything is approved. If you're approaching your goal and thinking through next steps, that review is the right place to raise it. You can also read more about how the prescribing process works by visiting who we are or reviewing the common questions our patients ask. And if you're still in the early part of treatment and thinking ahead, when weight loss typically begins on Mounjaro gives a grounded picture of the journey from the start.

When you're ready to talk through your treatment with a prescriber, check your eligibility with a free consultation.